LivaNova (LIVN) Cash from Restructuring (2016 - 2020)
LivaNova (LIVN) posted Cash from Restructuring of -$277000.0 for Q3 2020, up 41.56% sequentially from -$474000.0 in Q2 2020, and up 78.58% YoY from -$155115.2 in Q4 2019.
LivaNova (LIVN) Cash from Restructuring (2016 - 2020) Analysis & Trends
LivaNova has reported Cash from Restructuring for 5 years, with the latest figure at -$277000.0 in Q3 2020.
- Quarterly Cash from Restructuring rose 78.58% year-over-year to -$277000.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was -$1.2 million (down 86.51% YoY) and the FY2019 annual result came in at -$6.7 million, down 203.74% from the prior year.
- Cash from Restructuring improved to -$277000.0 in Q3 2020 per LIVN's latest filing, from -$474000.0 in the prior quarter.
- Over five years, Cash from Restructuring peaked at $22.0 million in Q1 2016 and troughed at -$6.7 million in Q1 2017.
- A 5-year average of $89944.4 and a median of -$594000.0 in 2018 frame the typical range for Cash from Restructuring.
- The sharpest annual moves came in 2018 and 2019: Cash from Restructuring surged 440.13% in 2018, then slumped 1639.29% in 2019.
- Over 5 years, Cash from Restructuring stood at -$2.6 million in 2016, then increased by 29.42% to -$1.8 million in 2017, then soared by 440.13% to $6.1 million in 2018, then slumped by 99.69% to $19000.0 in 2019, then slumped by 1557.89% to -$277000.0 in 2020.
- According to Business Quant data, Cash from Restructuring over the past three periods registered -$277000.0, -$474000.0, and -$443000.0 for Q3 2020, Q2 2020, and Q1 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -277,000.00 |
| Jun 30, 2020 | -474,000.00 |
| Mar 31, 2020 | -443,000.00 |
| Dec 31, 2019 | 19,000.00 |
| Sep 30, 2019 | -1.29 Mn |
| Jun 30, 2019 | -567,000.00 |
| Mar 31, 2019 | -4.91 Mn |
| Dec 31, 2018 | 6.14 Mn |
| Sep 30, 2018 | 84,000.00 |
| Jun 30, 2018 | -621,000.00 |
| Mar 31, 2018 | 905,000.00 |
| Dec 31, 2017 | -1.80 Mn |
| Sep 30, 2017 | -1.62 Mn |
| Jun 30, 2017 | -4.43 Mn |
| Mar 31, 2017 | -6.70 Mn |
| Dec 31, 2016 | -2.56 Mn |
| Sep 30, 2016 | -1.84 Mn |
| Mar 31, 2016 | 22.01 Mn |